4//SEC Filing
Intellia Therapeutics, Inc. 4
Accession 0001209191-17-002291
$NTLACIK 0001652130operating
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:57 PM ET
Size
5.4 KB
Accession
0001209191-17-002291
Insider Transaction Report
Form 4
Bell Graeme
EVP, Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2017-01-03+210,000→ 210,000 totalExercise: $13.48Exp: 2027-01-02→ Common Stock (210,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 3, 2017 with respect to 210,000 shares of Common Stock, with 25% vesting on December 12, 2017 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001652130
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 5:57 PM ET
- Size
- 5.4 KB